anewmeds.com (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Anew Medical, Inc. (WENA) miya uzoq umrligini ta'minlash maqsadida Altsgeymer kasalligiga qarshi kurashish uchun innovatsion gen terapiyasi usullarini ishlab chiqmoqda. Biroq, biznes daromadning yetishmasligi, potentsial tadqiqotlar muvaffaqiyatsizligi va tashqi investitsiyalarga bog'liqlik kabi tahdidlar bilan yuzlashmoqda. Jori ko'rsatkich 0.00 darajasida bo'lib, bu likvidlik tanqisligini ko'rsatadi. Quyidagi narxlar grafigi ushbu biotexnologiya startapining moliyaviy holatini aniq namoyish etadi.

anewmeds.com (WENA): Uzoq muddatli qarzning o'z kapitaliga nisbati 25.06.2024dan 17.09.2024gacha

Anew Medical (WENA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi anewmeds.com|WENA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Anew Medical, Inc.|WENA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Anew Medical|WENA - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati anewmeds.com|WENA - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Anew Medical, Inc.|WENA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Anew Medical Inc.|WENA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Anew Medical, Inc.|WENA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Anew Medical|Tezkor likvidlik ko‘rsatkichi anewmeds.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
WENA - Sof daromad
Kompaniyaning har tomonlama tahlili:anewmeds.com WENA

Ushbu ko'rsatkich kompaniyaning bir yildan ortiq muddatli qarzlarga bo'lgan bog'liqligini baholaydi. Uzoq muddatli kredit yuki koeffitsiyentini tahlil qilish bizga kapitalga nisbatan haqiqiy qarz yukini aniqlash imkonini beradi. Ushbu metrika uzoq muddatli qarz miqdorini aktivlarning umumiy qiymatidan majburiyatlarni ayirgan holda bo'lish orqali hisoblanadi. Anew Medical (WENA) uchun past qarz darajasi ALS terapiyasi bo'yicha noyob patentlardan foydalanish uchun juda muhimdir. Bu himoyalangan biotexnologik ishlanmalar ishlab chiqilishi davrida moliyaviy barqarorlikni ta'minlaydi.

Muhim raqobatchilar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Amylyx Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Praxis Corp (PRAX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|AVXL: Uzoq muddatli qarzning o'z kapitaliga nisbati|ceribell.com (CBLL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alector - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Omeros Corp. (OMER)|Uzoq muddatli qarzning kapitalga nisbati NGNE|ACIU - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|NMRA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tevogen Bio Inc. TVGN|ACOG: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati cogrx.com|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Cassava Sciences Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|Uzoq muddatli qarzning o'z kapitaliga nisbati COYA (coyatherapeutics.com)|Vistagen - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti OVID|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati CervoMed, Inc. CRVO|alteritytherapeutics.com (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi CLNN|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati jupiterneurosciences.com (JUNS)|Uzoq muddatli qarzning o'z kapitaliga nisbati RLMD (Relmada Therapeutics, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati Annovis Bio Inc|Grace Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|AIFF - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NeuroSense Therapeutics|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi MTVA|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Helius Medical Technologies Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. (PASG)|bionomics.com.au - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati NERV (Minerva Neurosciences, Inc.)|Athira Pharma Inc (ATHA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ADXN: Uzoq muddatli qarzning o'z kapitaliga nisbati|ALZN - Uzoq muddatli qarzning kapitalga nisbati|cyclerion.com (CYCN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protagenic Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics Corp|Uzoq muddatli majburiyatlarning kapitalga nisbati Cortigent Medical CRGT|Uzoq muddatli qarzning kapitalga nisbati ATXI|Uzoq muddatli qarzning kapitalga nisbati BrainStorm Cell Therapeutics Inc. (BCLI)|Uzoq muddatli qarzning o'z kapitaliga nisbati Cara Therapeutics, Inc. CARA|CHRO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Eliem - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Intra-Cellular Therapies|LBPH (Longboard Pharma) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Marinus Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati NKGN|NRBO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Sage Therapeutics (SAGE)|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix Inc. SNPX|Uzoq muddatli qarzning kapitalga nisbati TRVN (Trevena, Inc)|Vigil Neuroscience Inc. (VIGL) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati